Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19
NCT04336904
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
Favipiravir
OTHER:
Placebo
Sponsor
Giuliano Rizzardini